Close
Help
Need Help?



Calls for Papers Updated

Posted Thu, Sep, 06,2012

We are pleased to announce that all calls for papers have been updated and submissions are now being accepted for peer review.  Our journals offer a unique set of benefits designed to provide authors with a high-quality, efficient publishing service:Visibility: journals are open access, widely indexed by popular databases such as Pubmed, Scopus and DOAJ, and now offer an industry-leading arti...

Continue Reading →

Posted in: Calls for Papers

Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders Now on JournalTOCs and 10 Other Directories

Posted Wed, Sep, 05,2012

Libertas is pleased to announce that Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders is now included in the JournalTOCs (Journal Tables of Contents) directory and content is available through the website now.JournalTOCs contains metadata from over 17,000 journals collected from almost 1,000 international publishers. The directory is free for anyone to browse the latest news, ar...

Continue Reading →

Clinical Medicine Insights: Pediatrics Medicine Joins COPE

Posted Wed, Sep, 05,2012

Clinical Medicine Insights: Pediatrics has formally joined the Committee on Publishing Ethics.COPE provides guidelines that are applied in situations such as where plagiarism allegations are made against a paper.  By becoming a COPE member there can be no doubt amongst authors of questionable papers that journals will apply commonly accepted industry-standard guidelines.  In more difficu...

Continue Reading →

Cancer Informatics Added to Gale InfoTrac Custom Journals

Posted Wed, Sep, 05,2012

Libertas is pleased to announce that Cancer Informatics has now been added to Gale's InfoTrac Custom Journals database.GALE operates more than 600 databases, including the popular InfoTrac and General Reference series. The Michigan based company is popular with authors working in the USA, so inclusion of Cancer Informatics in GALE's InfoTrac Custom Journals will increase article visibility...

Continue Reading →

Clinical Medicine Insights: Pathology Now Uses Project Counter Analytics

Posted Wed, Sep, 05,2012

Enhanced visibility is one of the prime advantages to authors of publishing in an open access journal like Clinical Medicine Insights: Pathology.One of the ways we measure an article's visibility is the number of views and downloads it receives.  The resulting number is available on the journal's webpages for each article, and by adding those numbers together we obtain the journal'...

Continue Reading →

Most read paper in Cell Biology Insights

Posted Wed, Sep, 05,2012

Cell Biology Insights is an open access journal, meaning all articles are available for anyone to download freely without restriction. Open access journals are renowned for having high levels of article visibility compared to traditional subscription journals.One good example of how open access journals can offer high visibility is 'A Salt-Threshold Required for Exacerbating Insulin Resistance...

Continue Reading →

Our Service Promise

  • Prompt Processing (3 Weeks to Editorial Decision)
  • Fair, Independent Peer Review
  • High Visibility & Extensive Indexing
What Your Colleagues Say About Libertas Academica
Publishing in Gene Regulation and Systems Biology was a very positive experience.  I was impressed by the fast and uncomplicated submission process as well as the clear and professional peer review process which helped to improve the manuscript.  The Libertas Academica team was very patient and helpful.  I would definitely recommend the journal to other colleagues in the field!
Dr Cameron Moshfegh (Federal Institute of Technology, Switzerland)
More Testimonials

Quick Links




Follow Us We make it easy to find new research papers.




SUBJECT HUBS
Author Survey Results
author_survey_results
All authors are surveyed after their articles are published. Authors are asked to rate their experience in a variety of areas, and their responses help us to monitor our performance. Presented here are their responses in some key areas. No 'poor' or 'very poor' responses were received; these are represented in the 'other' category.
See Our Results